Human services: medical services; coverage for the prophylaxis, diagnosis, and treatment of certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1939 PA 280 (MCL 400.1 - 400.119b) by adding sec. 109v.
Impact
The proposed amendment to the Social Welfare Act could significantly affect how pediatric autoimmune neuropsychiatric disorders are managed under state medical assistance. Coverage must not impose greater copayments, deductibles, or coinsurance compared to other benefits. This change may alleviate the financial burden on families struggling with these conditions, ensuring that necessary treatments are accessible without additional cost barriers. Moreover, coverage must be provided in a timely manner corresponding to the severity of the patient's condition, which enhances the urgency and responsiveness of medical care.
Summary
House Bill 5136 aims to expand medical coverage under Michigan's medical assistance program to include the prophylaxis, diagnosis, and treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome. These conditions will be covered when prescribed or ordered by a physician or provider, encompassing various treatments such as antibiotics, medication, behavioral therapies, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin therapy. This bill signifies a forward step in recognizing and addressing specific pediatric health needs that have long been overlooked in existing legislation.
Contention
Notably, the bill stipulates that individuals cannot be denied or delayed coverage based on prior treatments for the same or similar conditions. This inclusion aims to protect patients from treatment denial associated with previous diagnoses, broadening access to care for children with complex medical histories. By requiring that treatments be coded and billed under specific diagnostic codes unless new codes are established, the bill ensures consistent medical record management. However, it's expected to stir discussions regarding the adequacy of resources allocated to support these new provisions within the medical assistance program.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Extends coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome by removing the sunset date of December 31, 2025, and mandating such coverage.
State plan for medical assistance services and health insurance; pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Extends coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome by removing the sunset date of December 31, 2025, and mandating such coverage.